Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University Health Network, Toronto
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Fudan University
Hospital Israelita Albert Einstein
UNICANCER
MedSIR
Instituto do Cancer do Estado de São Paulo
Sun Yat-sen University